EUVIMEDEUVIMED entdecken
Open Access

Single-institution experience of 500 pulmonary resections guided by intraoperative molecular imaging

Gregory T Kennedy, Feredun S Azari, Ashley Chang, Bilal Nadeem, Elizabeth Bernstein, Alix Segil, Azra Din, Charuhas Desphande, Olugbenga Okusanya, Jane Keating, Jarrod Predina, Andrew Newton und 2 weitere

The Journal of Thoracic and Cardiovascular Surgery · 2023

DOI: 10.1016/j.jtcvs.2022.12.023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2023. Verfasst von Gregory T Kennedy und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pa. Hauptthemen laut MEDLINE: Lung Neoplasms, Pleural Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, American Philosophical Society, Society of Thoracic Surgeons.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Intraoperative molecular imaging (IMI) using tumor-targeted optical contrast agents can improve thoracic cancer resections. There are no large-scale studies to guide surgeons in patient selection or imaging agent choice. Here, we report our institutional experience with IMI for lung and pleural tumor resection in 500 patients over a decade. METHODS: Between December 2011 and November 2021, patients with lung or pleural nodules undergoing resection were preoperatively infused with 1 of 4 optical contrast tracers: EC17, TumorGlow, pafolacianine, or SGM-101. Then, during resection, IMI was used to identify pulmonary nodules, confirm margins, and identify synchronous lesions. We retrospectively reviewed patient demographic data, lesion diagnoses, and IMI tumor-to-background ratios (TBRs). RESULTS: Five hundred patients underwent resection of 677 lesions. We found that there were 4 types of clinical utility of IMI: detection of positive margins (n = 32, 6.4% of patients), identification of residual disease after resection (n = 37, 7.4%), detection of synchronous cancers not predicted on preoperative imaging (n = 26, 5.2%), and minimally invasive localization of nonpalpable lesions (n = 101 lesions, 14.9%). Pafolacianine was most effective for adenocarcinoma-spectrum malignancies (mean TBR, 2.84), and TumorGlow was most effective for metastatic disease and mesothelioma (TBR, 3.1). False-negative fluorescence was primarily seen in mucinous adenocarcinomas (mean TBR, 1.8), heavy smokers (>30 pack years; TBR, 1.9), and tumors greater than 2.0 cm from the pleural surface (TBR, 1.3). CONCLUSIONS: IMI may be effective in improving resection of lung and pleural tumors. The choice of IMI tracer should vary by the surgical indication and the primary clinical challenge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsPleural NeoplasmsHumansRetrospective StudiesLungMolecular ImagingFolic Acid

Stichwörter der Autor:innen

intraoperative molecular imaginglung cancermesotheliomapulmonary metastases

Substanzen

PafolacianineFolic Acid

Autor:innen und Institutionen

  • Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pa.
  • Department of Pathology, University of Pennsylvania School of Medicine, Philadelphia, Pa.
  • Department of Surgery, Jefferson University Hospital, Philadelphia, Pa.
  • Department of Surgery, Hartford Hospital, Hartford, Conn.
  • Department of Surgery, Massachusetts General Hospital, Boston, Mass.
  • Department of Surgery, MD Anderson Cancer Center, Houston, Tex.

Förderung

  • NCI NIH HHS
  • American Philosophical Society
  • Society of Thoracic Surgeons
  • National Institutes of Health
  • Foundation for the National Institutes of Health

Zitieren

APA

Kennedy, G. T., Azari, F. S., Chang, A., Nadeem, B., Bernstein, E., Segil, A., Din, A., Desphande, C., Okusanya, O., Keating, J., Predina, J., Newton, A., Kucharczuk, J. C., & Singhal, S. (2023). Single-institution experience of 500 pulmonary resections guided by intraoperative molecular imaging. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2022.12.023

Vancouver

Kennedy GT, Azari FS, Chang A, Nadeem B, Bernstein E, Segil A, et al. Single-institution experience of 500 pulmonary resections guided by intraoperative molecular imaging. The Journal of Thoracic and Cardiovascular Surgery. 2023. doi:10.1016/j.jtcvs.2022.12.023

BibTeX
@article{Kennedy2023,
  author = {Kennedy, Gregory T and Azari, Feredun S and Chang, Ashley and Nadeem, Bilal and Bernstein, Elizabeth and Segil, Alix and Din, Azra and Desphande, Charuhas and Okusanya, Olugbenga and Keating, Jane and Predina, Jarrod and Newton, Andrew and Kucharczuk, John C and Singhal, Sunil},
  title = {Single-institution experience of 500 pulmonary resections guided by intraoperative molecular imaging},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2023},
  doi = {10.1016/j.jtcvs.2022.12.023}
}
Kostenlos starten →